Improving equitable access to genomics-based clinical trials remains a critical priority in cancer care, according to Dr.
Demonstrating faster, simpler, more cost-efficient NGS workflows that turn complex agrigenomics data into practical ...
In January 2026, 10x Genomics, Inc. reported preliminary 2025 results showing about US$166.0 million in fourth-quarter ...
The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...
KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...
Illumina has named Eric Green as chief medical officer, providing a home to the first National Institutes of Health director ...
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select ...
Enhanced Genomics ('Enhanced' or 'the Company'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for co ...
A MAJOR international scientific collaboration bringing together the University of Guyana and leading research institutions ...
Cathie Wood is making a massive bet on gene editing, pouring $5.4 billion into companies like Beam Therapeutics while selling ...
StockStory.org on MSN
Why 10x Genomics (TXG) shares are falling today
What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 4.7% in the afternoon session after the company ...
India’s health care system is undergoing a major shift as genomics and artificial intelligence enable predictive, preventive, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback